JP2024523524A5 - - Google Patents
Info
- Publication number
- JP2024523524A5 JP2024523524A5 JP2023579269A JP2023579269A JP2024523524A5 JP 2024523524 A5 JP2024523524 A5 JP 2024523524A5 JP 2023579269 A JP2023579269 A JP 2023579269A JP 2023579269 A JP2023579269 A JP 2023579269A JP 2024523524 A5 JP2024523524 A5 JP 2024523524A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- independently
- conjugate compound
- ch2c
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/102377 | 2021-06-25 | ||
| CN2021102377 | 2021-06-25 | ||
| PCT/CN2022/101108 WO2022268202A1 (zh) | 2021-06-25 | 2022-06-24 | 配体药物偶联物及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024523524A JP2024523524A (ja) | 2024-06-28 |
| JP2024523524A5 true JP2024523524A5 (enExample) | 2025-07-02 |
Family
ID=84544230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023579269A Pending JP2024523524A (ja) | 2021-06-25 | 2022-06-24 | リガンド薬物コンジュゲート及びその応用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240358843A1 (enExample) |
| EP (1) | EP4360654A4 (enExample) |
| JP (1) | JP2024523524A (enExample) |
| KR (1) | KR20240025514A (enExample) |
| CN (1) | CN117693365A (enExample) |
| AU (1) | AU2022296571A1 (enExample) |
| CA (1) | CA3224741A1 (enExample) |
| IL (1) | IL309543A (enExample) |
| MX (1) | MX2023015286A (enExample) |
| TW (1) | TW202317199A (enExample) |
| WO (1) | WO2022268202A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7767613B2 (ja) | 2021-11-15 | 2025-11-11 | システィミューン，インコーポレイテッド | 二重特異性抗体－カンプトテシン薬物複合体及びその製薬的使用 |
| KR20240142405A (ko) * | 2021-11-17 | 2024-09-30 | 씨에스피씨 메가리스 바이오파마슈티칼 씨오., 엘티디. | 항체-약물 복합체 및 그의 용도 |
| WO2024131944A1 (zh) * | 2022-12-23 | 2024-06-27 | 同宜医药（苏州）有限公司 | 药物组合物及其制备方法和用途 |
| IL322887A (en) * | 2023-02-27 | 2025-10-01 | Suzhou Suncadia Biopharmaceuticals Co Ltd | Anti-DLL3 antibody, antibody-drug conjugate and pharmaceutical use thereof |
| CN121001746A (zh) * | 2023-04-26 | 2025-11-21 | 同宜医药（苏州）有限公司 | 一种配体-药物偶联体在治疗癌症中的用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2478543A1 (en) * | 2001-10-26 | 2003-04-26 | The Uab Research Foundation | Multidrug multiligand conjugates for targeted drug delivery |
| AU2013288932A1 (en) * | 2012-07-09 | 2014-12-11 | Genentech, Inc. | Immunoconjugates comprising anti - CD79b antibodies |
| CN104784699B (zh) * | 2014-01-20 | 2019-05-03 | 博瑞生物医药（苏州）股份有限公司 | 叶酸受体结合配体-药物偶联物 |
| CA2987322C (en) * | 2015-08-11 | 2020-02-11 | Coherent Biopharma | Multi-ligand drug conjugates and uses thereof |
| CN107412794B (zh) * | 2017-04-17 | 2019-01-04 | 中国医学科学院北京协和医院 | 双靶点显像分子探针及其制备方法和应用 |
| US20210353652A1 (en) * | 2018-06-04 | 2021-11-18 | Trustees Of Tufts College | Tumor microenvironment-activated drug-binder conjugates, and uses related thereto |
| JP7546574B2 (ja) * | 2019-01-30 | 2024-09-06 | コヒレント バイオファーマ （スーチョウ），リミテッド | 二重リガンド薬物コンジュゲート及びその使用 |
-
2022
- 2022-06-24 TW TW111123557A patent/TW202317199A/zh unknown
- 2022-06-24 WO PCT/CN2022/101108 patent/WO2022268202A1/zh not_active Ceased
- 2022-06-24 EP EP22827694.5A patent/EP4360654A4/en active Pending
- 2022-06-24 US US18/573,083 patent/US20240358843A1/en active Pending
- 2022-06-24 MX MX2023015286A patent/MX2023015286A/es unknown
- 2022-06-24 IL IL309543A patent/IL309543A/en unknown
- 2022-06-24 KR KR1020237042917A patent/KR20240025514A/ko active Pending
- 2022-06-24 CN CN202280044473.4A patent/CN117693365A/zh active Pending
- 2022-06-24 JP JP2023579269A patent/JP2024523524A/ja active Pending
- 2022-06-24 AU AU2022296571A patent/AU2022296571A1/en active Pending
- 2022-06-24 CA CA3224741A patent/CA3224741A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021006549A5 (enExample) | ||
| JP2023025151A5 (enExample) | ||
| EP2750681B1 (en) | Branched discrete peg constructs | |
| US11970583B2 (en) | Therapeutic dendrimer | |
| US20080267903A1 (en) | Bioactive Polymers | |
| JP6876618B2 (ja) | 治療目的のための抗体−ウレアーゼコンジュゲート | |
| JP2023538071A5 (enExample) | ||
| JP2005533029A5 (ja) | 悪性新生物および他の過剰増殖性疾患の治療におけるラクトフェリン | |
| US12576154B2 (en) | Conjugates of PSMA-binding moieties with cytotoxic agents | |
| JP2020518610A5 (enExample) | ||
| JPWO2020027100A5 (enExample) | ||
| JP2024523524A (ja) | リガンド薬物コンジュゲート及びその応用 | |
| WO2024056101A1 (zh) | 用于抗体药物偶联物的连接子及其应用 | |
| JP2023505509A (ja) | ポリエチレングリコール複合薬、ならびにその調製方法およびその使用 | |
| WO2019169837A1 (zh) | 白蛋白结合型吉西他滨前药及其合成和应用 | |
| TW202304517A (zh) | 蛋白—大分子綴合物及其使用方法 | |
| JP2026510850A (ja) | リンカー及びそれを使用したカップリング薬物、抗体薬物複合体並びにその応用 | |
| ES2428863T3 (es) | Mutante de factor estimulante de colonias de granulocitos (G-CSF) y polipéptido químicamente del mismo | |
| CN108653746B (zh) | 一种多载药点、高载药配基药物偶联物 | |
| US20220395525A1 (en) | Therapeutic dendrimer | |
| JP7734891B2 (ja) | 新規な構造を有するポリペプチド薬物複合体及びその使用 | |
| US20210137957A1 (en) | Modified anthracycline compounds and their therapeutic use | |
| US12071517B2 (en) | Therapeutic dendrimer | |
| CN109982720A (zh) | 抗体药物缀合物 | |
| RU2024101598A (ru) | Конъюгат лиганда и лекарственного средства и его применение |